January 13, 2022 Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending February 28, 2022 [Japanese GAAP] Company name: Hisamitsu Pharmaceutical Co., Inc. Stock exchange listing: Tokyo, Nagoya, Fukuoka Securities code: 4530 URL: https://global.hisamitsu/ Representative: NAKATOMI Kazuhide, President & CEO TAKAO Shinichiro, Managing Director & Executive Officer, Management of Public Relations, Investor Relatoions Contact TEL: +81-3-5293-1704 Scheduled date of filing quarterly securities report: Scheduled date of dividend payment: Jan. 14, 2022 ― Preparation of supplementary materials for quarterly financial results: Yes Holding of quarterly financial results meeting: Yes (for institutional investors and analysts) 1. Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending February 28, 2022 (March 1, 2021 to November 30, 2021) (1) Consolidated Operating Results (Percentages represent year-on-year changes) (Amounts are rounded down to the nearest millions of yen) Net sales Operating profit Ordinary profit Nine months ended Nov. 30, 2021 86,663 7.2 6,973 △14.2 8,665 9.3 6,218 Nine months ended Nov. 30, 2020 80,822 △18.4 8,123 △55.9 7,928 △60.2 5,722 △62.9 Millions of yen % Millions of yen % Millions of yen % Millions of yen (Note) Comprehensive income: Nine months ended Nov. 30, 2021 9,349 millions of yen (36.2%) Nine months ended Nov. 30, 2020 6,865 millions of yen (△47.0%) Profit attributable to owners of parent % 8.7 Profit per share Diluted profit per share Nine months ended Nov. 30, 2021 Nine months ended Nov. 30, 2020 (2) Consolidated Financial Position yen 76.14 70.04 yen 76.09 69.97 Total assets Net assets Shareholders’ equity ratio As of Nov. 30, 2021 As of Feb. 28, 2021 Millions of yen Millions of yen 303,995 299,861 253,913 253,809 % 82.9 84.1 (Reference) Shareholders’ equity: As of Nov. 30, 2021 251,971 millions of yen As of Feb. 28, 2021 252,066 millions of yen 2. Dividends Year ended Feb. 28, 2021 Year ending Feb. 28, 2022 Year ending Feb. 28, 2022 (Forecast) First quarter Second quarter Third quarter Fiscal year end Total Annual dividends yen ― ― yen 41.75 42.00 yen ― ― yen 41.75 42.00 yen 83.50 84.00 (Note) Revisions to the mst recently announced dividends forecast: No 3. Consolidated Earnings Forecast for the Fiscal Year Ending February 28, 2022 (March 1, 2021 to February 28, 2022) Net sales Operating profit Ordinary profit (Percentages represent year-on-year changes) Profit attributable to owners of parent Profit per share Full year Millions of yen 122,900 % 7.3 Millions of yen 10,700 % Millions of yen 12,700 0.3 % Millions of yen 9,900 7.4 % 7.0 yen 121.22 (Note) Revisions to the most recently announced consolidated forecast: No *Notes (1) Changes in significant subsidiaries during the period (Chages in specified subsidiaries resulting in changes in scope of consolidation) (2) Apprication of special accounting methods for preparation of quarterly consolidated financial statements (3) Changes in accounting policies, changes in accounting estimates, and restatement 1) Changes in accounting policies due to revision of accounting standards 2) Changes in accounting policies other than 1) above 3) Changes in accounting estimates 4) Restatement (4) The number of shares outstanding (common stock) 1) Total number of shares outstanding at the end of the period (including treasury stock) : None : Yes : Yes : None : None : None As of Nov. 30, 2021 As of Feb. 28, 2021 : 85,164,895 shares : 85,164,895 shares 2) Total number of treasury stock at the end of the period As of Nov. 30, 2021 As of Feb. 28, 2021 : 4,025,727 shares : 3,430,483 shares 3) Average number of shares outstanding during the period Nine months ended Nov. 30, 2021 Nine months ended Nov. 30, 2020 : 81,670,294 shares : 81,698,419 shares *Quarterly financial results reports are not subjected to quarterly review. *Explanation for appropriate use of financial forecasts and other special notes Among this document, the forecasts based on the plan may changes due to uncertain factors. Therefore, the actual operating results may differ from the company’s view. Financial settlement briefings for institutional investors and analysts will be held on January 13, 2022. Presentation materials of financial results will be posted promptly on the company’s website after the financial settlement briefings. Quarterly Consolidated Financial Statements (1) Quarterly Consolidated Balance sheets Prior Fiscal Year End (As of Feb. 28, 2021) Current Third Quarter (As of Nov. 30, 2021) (Millions of yen) 119,908 33,083 23,107 10,012 532 6,890 10,859 △405 203,988 13,746 24,733 38,480 458 938 1,397 51,293 9,049 △214 60,128 100,007 303,995 114,254 39,546 21,743 11,359 465 6,744 4,290 △343 198,061 14,180 23,174 37,354 27 1,150 1,178 54,602 8,878 △214 63,267 101,800 299,861 Assets Current assets Cash and deposits Notes and accounts receivable – trade Securities Merchandise and finished goods Work in process Raw materials and supplies Other Allowance for doubtful accounts Total current assets Non-current assets Property, plant and equipment Buildings and structures, net Other, net Total property, plant and equipment Intangible assets Sales rights Other Total intangible assets Investments and other assets Investment securities Other Allowance for doubtful accounts Total investments and other assets Total non-current assets Total assets Prior Fiscal Year End (As of Feb. 28, 2021) Current Third Quarter (As of Nov. 30, 2021) (Millions of yen) 7,167 5,582 1,111 1,668 118 490 18,150 34,289 238 8,132 7,422 15,793 50,082 8,473 2,356 232,753 △13,908 229,674 14,261 3,784 3,861 389 22,296 244 1,697 253,913 303,995 7,672 7,127 1,111 608 103 1,350 12,082 30,057 296 7,928 7,769 15,994 46,051 8,473 2,352 233,376 △11,495 232,707 16,165 3,790 △1,173 575 19,359 232 1,510 253,809 299,861 Liabilities Current liabilities Notes and accounts payable – trade Electronically recorded obligations – operating Short-term loans payable Income taxes payable Provision for sales returns Provision for bonuses Other Total current liabilities Non-current liabilities Long-term loans payable Net defined benefit liability Other Total non-current liabilities Total liabilities Net assets Shareholders’ equity Capital stock Capital surplus Retained earnings Treasury shares Total shareholders’ equity Accumulated other comprehensive income Valuation difference on available-for-sale securities Revaluation reserve for land Foreign currency translation adjustment Remeasurements of defined benefit plans Total accumulated other comprehensive income Share acquisition rights Non-controlling interests Total net assets Total liabilities and net assets (2) Quarterly Consolidated Statements of Income and Comprehensive Income Quarterly Consolidated Statements of Income Prior Fiscal Year (Mar. 1, 2020 – Nov. 30, 2020) Current Fiscal Year (Mar. 1, 2021 – Nov. 30, 2021) (Millions of yen) 86,663 34,884 51,779 44,805 6,973 110 595 891 329 1,927 11 ― 74 77 72 235 8,665 6 652 659 53 279 333 8,992 2,564 6,427 209 6,218 80,822 30,184 50,674 42,551 8,123 507 570 ― 390 1,467 5 1,149 208 ― 299 1,662 7,928 219 136 356 21 ― 21 8,263 2,409 5,853 131 5,722 Share of loss of entities accounted for using equity method Selling, general and administrative expenses Net sales Cost of sales Gross profit Operating profit Non-operating income Interest income Dividend income Foreign exchange gains Other Total non-operating income Non-operating expenses Interest expenses Foreign exchange losses Cost for idle operation Other Total non-operating expenses Ordinary profit Extraordinary income Gain on disposal of non-current assets Gain on sales of investment securities Total extraordinary income Extraordinary losses Loss on disposal of non-current assets Loss on discontinuation of sale Total extraordinary losses Profit before income taxes Income taxes Profit Profit attributable to non-controlling interests Profit attributable to owners of parent Prior Fiscal Year (Mar. 1, 2020 – Nov. 30, 2020) Current Fiscal Year (Mar. 1, 2021 – Nov. 30, 2021) Quarterly Consolidated Statements of comprehensive income Profit Other comprehensive income Valuation difference on available-for-sale securities Foreign currency translation adjustment Remeasurements of defined benefit plans, net of tax Share of other comprehensive income of entities accounted for using equity method Total other comprehensive income Comprehensive income Comprehensive income attributable to Comprehensive income attributable to owners of parent Comprehensive income attributable to non-controlling interests 5,853 3,556 △2,698 146 7 1,011 6,865 6,767 97 (Millions of yen) △1,855 6,427 5,013 △193 △42 2,922 9,349 9,161 187
